THE FAUCI FILES, Vol 3(6): Anthrax Vaccine Scam Unravels, Part III

fred fredshaw at primenet.com
Sat Jan 22 11:24:13 EST 2000


THE FAUCI FILES, Vol 3(6): Anthrax Vaccine Scam Unravels, Part III

January 20, 2000

  "In the continuing unfolding story of the vaccines produced by 
   the Michigan Biological Products Institute, MBPI, there is some 
   disagreement within FDA and DoD as to who is responsible for 
   inspecting the anthrax vaccine line. The FDA has the authority 
   and responsibility for inspecting vaccine production."

  "However according to the inspection report of the November 1996 
   FDA inspection at MBPI, the FDA did not cover the anthrax 
   vaccine inspection "since it comes under military inspection." 
   The DoD Health Affairs Office says the FDA inspects the anthrax 
   vaccine line, not the military. But according to Dr. Robert 
   Meyers, COO, the Army does inspect the anthrax vaccine line, 
   but the FDA has not relinquished authority to the DoD."

  "The FDA inspectors have said that until recently, the anthrax 
   vaccine line was inspected only by the military. The concern 
   has been that if FDA has given an exception to DoD for the 
   anthrax vaccine, is DoD responsible for the safety and efficacy 
   of the vaccine?"

  "Other reports have said that the DoD owns and maintains the 
   anthrax vaccine line. Who inspects the anthrax vaccines given 
   to veterinarians and meat handlers?"

The NIH/NIAID Direktor, Dr. Anthony "Mussolini" Fauci, is at the 
center of the bureaucrat web of responsibility for ALL vaccines.

  "MBPI makes the pertussis vaccine, rabies vaccine and 
   diphtheria, pertussis, tetanus vaccine components, as well as 
   plasma derivatives of albumin and immune globulin. In fact, 
   according to some reports, MBPI is the only source of immune 
   globulin."

Why is Dr. Fauci's administration plagued with corruption,
a fraudulent IL-2 patent by Fauci himself and unholy alliances 
with the sleazy Pharmaceutical Fascists who represent and 
reward "the favored few" at the expense of ALL others?

   "Editor's Note: Assured Capital Return - to the Max!: In 
    September start-up company BioPort Corp. bought the only US 
    manufacturer of anthrax vaccine, the MBPI for a reported 
    $25 million. This included around $3.25M in cash and the 
    rest in IOU?s. Within three weeks, BioPort "won" a Pentagon 
    contract for $29 million to supply anthrax vaccine. Fortune 
    smile$ on the favored few."

Interestingly, this military-distributed digest does 
NOT report the name of the primary perpetrator at BioPort who 
is a partner in this company despite the fact that he never 
invested as much as a single penny in the buyout with 
his "partners":

    ex-Chairman, Joint Chiefs of Staff, Admiral Crowe

The question remains:
Who was harmed or killed by the CONTAMINATED anthrax vaccine that
remains locked "in storage" due to "problems", the precise
nature of which have been subjected to the bureaucratic
conspiracy of silence?

Why has Fauci remained silent about a recent peer-reviewed
journal article that reported toxic levels of mercury
used as preservatives for vaccines under Fauci's tutelage?

Why has Dr. Anthony Fauci remained silent over the recent
journal article which reported that the very best technology
today CANNOT adequately detect the presence of Hepatitis C
virus in vaccines or in the blood supply?

Why does the NIH/NIAID stonewall and REFUSE to disclose
Fauci's personal FINANCIAL CONFLICTS OF INTEREST on the basis
that NIH "public servants" enjoy protection from public
Freedom of Information Act disclosure of ANY "financial information"?

Is Janet Reno, the U.S. Attorney General, so impaired by Parkinson's
Disease (and her "buddy system" with Fauci's boss Donna "Do Nothing"
Shalala) that she can't see what the hell is going on here?

Has the "soft money" corporate donations to our sold-out
"representatives" in Congress turned ALL of them into a
collective brothel for the large corporations?

As to our "Ethics President", William Jefferson Clinton, you
simply will not believe what his OUTRAGEOUS response has been 
-- this, of course, will be covered in an upcoming edition of
THE FAUCI FILES.

Crooked Murdering Bastards !

fred
====

THE ASA NEWSLETTER
Applied Science and Analysis Inc.
ISSN 1057-9419
Editor: Col. Richard Price


http://www.asanltr.com/ASANews-98/anthrax.html

                        BIOSCOPE '98

                    by Dr. Barbara Price

Vaccines

Vaccines stimulate the immune system and elicit immune 
responses. Ideally the response to the vaccine is the 
development of antibodies that will attack the antigen and 
prevent it from infecting the animal or human. Vaccine 
development is still an art, although the understanding of the 
science is increasing quickly. In retrospect, Edward Jenner and 
mankind were fortunate that the cowpox vaccine worked to 
prevent smallpox infections.

Our understanding is improving and our technology to develop 
new vaccines is moving forward rapidly, but our understanding 
is incomplete. The use of adjuvants to enhance vaccine potency 
is still more in the realm of art, not science.  Many adjuvants 
are oily substances (often hydrocarbons such as paraffin and 
squalene) that promote protein aggregation, which serves as a 
slow releasing reserve when mixed with an antigen.

While adjuvants may enhance some vaccines, adjuvants can 
themselves cause diseases. Human adjuvant disease was first 
described by women who had injections with silicone, paraffin, 
and other unknown compounds. It is a multi-symptom disease 
characterized by rheumatoid arthritis, systemic sclerosis, and 
other complaints of connective tissues.

Adding experimental adjuvants to existing licensed and approved 
vaccines for humans is medical experimentation. Recent research 
submitted to well known professional journals has implicated 
squalene, which has been used as an adjuvant in animal 
vaccines, in the blood sera of many patients with Gulf War 
Syndrome.  In this study, antibodies to squalene have been 
found in almost all of the GWS patients and has been absent in 
Gulf War veterans who do not have those symptoms. These same 
squalene antibodies were present in a small group of people who 
volunteered for vaccine trials in which squalene adjuvant was 
used as a placebo. Squalene may act in a manner similar to 
silicone in inducing autoimmune symptoms. And we need to pay 
attention to this research. 

Hopefully we will not find that our Gulf War veterans were an 
unknowing part of a medical experiment that was not fully 
thought out and was possibly illegal. Given the risk the US 
perceived at the time of the Gulf War, whenIraq?s BW program 
was suspected, but not proven, there were reasons to expedite 
the vaccination program for those who might be exposed. 
However, if adjuvants were added to licensed and approved 
vaccines, those given the enhanced vaccines should have been 
told.

In this context, perhaps the money spent by the government on 
project management, adherence to federal regulations and 
integrated management of timely FDA licensure for up to 18 
vaccines to be used by U.S. troops faced with biological 
warfare agents is not frivolous. Perhaps it is money wisely 
spent and the contractual requirement for this adherence 
reflects a concern within the US DoD's Biological Acquisition 
Program that mistakes not be repeated. But if this is true, the 
JVAP activities (DoD and contractor) need to be closely 
monitored. The same people, perhaps in different positions, may 
still be making decisions on our vaccine policies.

Anthrax Vaccination Update
In the continuing unfolding story of the vaccines produced by 
the Michigan Biological Products Institute, MBPI, there is some 
disagreement within FDA and DoD as to who is responsible for 
inspecting the anthrax vaccine line. The FDA has the authority 
and responsibility for inspecting vaccine production. 

However according to the inspection report of the November 1996 
FDA inspection at MBPI, the FDA did not cover the anthrax 
vaccine inspection "since it comes under military inspection." 
The DoD Health Affairs Office says the FDA inspects the anthrax 
vaccine line, not the military. But according to Dr. Robert 
Meyers, COO, the Army does inspect the anthrax vaccine line, 
but the FDA has not relinquished authority to the DoD. 

The FDA inspectors have said that until recently, the anthrax 
vaccine line was inspected only by the military. The concern 
has been that if FDA has given an exception to DoD for the 
anthrax vaccine, is DoD responsible for the safety and efficacy 
of the vaccine? And if so, the DoD cannot say the FDA has 
approved the anthrax vaccine. How much distance is the FDA 
putting between it and the anthrax vaccine? Other reports have 
said that the DoD owns and maintains the anthrax vaccine line. 
Who inspects the anthrax vaccines given to veterinarians and 
meat handlers? 

MBPI makes the pertussis vaccine, rabies vaccine and 
diphtheria, pertussis, tetanus vaccine components, as well as 
plasma derivatives of albumin and immune globulin. In fact, 
according to some reports, MBPI is the only source of immune 
globulin. According to the PRNewswire report announcing the $29 
million dollar award to BioPort Corp. for anthrax vaccine 
production, BioPort expects to earn most of its revenue from 
the sale of the anthrax vaccines to DoD and from its plasma 
fractionation services.

Antimicrobial Agent for Anthrax
University of Michigan and Novavax, Inc. of Columbia Maryland 
have tested a chemical mixture, BCTP, against both anthrax and 
the flu virus and found it effective. BCTP is an emulsion of 
water, soybean oil, Triton X 100 and tri-n-butyl phosphate. The 
BCTP killed most of the anthrax spores (Bacillus anthracis) in 
a culture dish. BCTP also reduced the mouse death rate to 20%, 
reduced skin lesions and swelling and helped to heal lesions on 
mouse skin after it was applied to lesions infected with a 
relative of anthrax, Bacillus cereus. 

In separate experiments, laboratory mice stayed healthy after 
BCTP, along with influenza A, was inserted into their nasal 
passages. Between these studies and the development of a 
vaccine based on protective antigen, it is possible that the 
"old-fashioned" vaccine produced by BioPort will quickly become 
obsolete.

Editor's Note: Assured Capital Return - to the Max!: In 
September start-up company BioPort Corp. bought the only US 
manufacturer of anthrax vaccine, the MBPI for a reported $25 
million. This included around $3.25M in cash and the rest in 
IOUs. Within three weeks, BioPort "won" a Pentagon contract 
for $29 million to supply anthrax vaccine. Fortune smile$ on 
the favored few. 


For the Professional in Government and Industry with an 
interest in Nuclear, Biological and Chemical Defense, 
Disarmament and Verification; Emergency and Disaster Medical 
Planning; Industrial Health and Safety; and Environmental 
Protection







More information about the Immuno mailing list